Analyst Reco. BioNTech SE

Equities

Real-time Estimate Cboe BZX Other stock markets 01:36:03 2024-05-08 pm EDT			5-day change	1st Jan Change
89.79 ^USD	-1.20%		-0.24%	-14.98%

05:37pm	HC Wainwright Raises BioNTech SE Price Target to $113 From $107, Maintains Buy Rating	MT
04:15pm	BIONTECH : Deutsche Bank reaffirms its Neutral rating	ZD

HC Wainwright Raises BioNTech SE Price Target to $113 From $107, Maintains Buy Rating	11:37am	MT
BIONTECH : Deutsche Bank reaffirms its Neutral rating	10:15am	ZD
TD Cowen Adjusts BioNTech Price Target to $98 From $95, Maintains Hold Rating	May. 07	MT
BMO Capital Adjusts BioNTech Price Target to $122 From $123, Maintains Outperform Rating	May. 07	MT
BIONTECH : Goldman Sachs reiterates its Neutral rating	May. 07	ZD
BIONTECH : Jefferies gives a Neutral rating	May. 06	ZD
BIONTECH : Gets a Neutral rating from Deutsche Bank	Apr. 23	ZD
UBS Cuts BioNTech Price Target to $101 From $110, Maintains Neutral Rating	Mar. 27	MT
BIONTECH : Deutsche Bank remains Neutral	Mar. 22	ZD
TD Cowen Adjusts BioNTech Price Target to $95 From $101, Maintains Market Perform Rating	Mar. 21	MT
BIONTECH : A miss is a miss	Mar. 21
BIONTECH : Deutsche Bank reaffirms its Neutral rating	Mar. 21	ZD
BIONTECH : Goldman Sachs reiterates its Neutral rating	Mar. 21	ZD
BIONTECH : Jefferies sticks Neutral	Mar. 20	ZD
BIONTECH : UBS gives a Neutral rating	Mar. 20	ZD
BMO Capital Initiates Coverage on BioNTech With Outperform Rating, $127 Price Target	Feb. 23	MT
Canaccord Genuity Adjusts Price Target on BioNTech to $171 From $168, Maintains Buy Rating	Feb. 20	MT
HC Wainwright Adjusts BioNTech Price Target to $107 From $133, Maintains Buy Rating	Jan. 23	MT
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge	Jan. 12	RE
BIONTECH : UBS sticks Neutral	Jan. 09	ZD

No results for this search

BIONTECH : A miss is a miss

March 21, 2024 at 09:27 am EDT